GlassScriptPhysician profile
Laura S Dill
NPI 1730157124
$5,467.65
in general payments reported to CMS, 2019-2025
11 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.92 · 2020: $1,829 · 2021: $2,087 · 2022: $1,162 · 2023: $39.31 · 2024: $166 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.05 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $2,061.53 | 2021 | |
| Gyrus Acmi, INC. | $1,815.00 | 2020 | |
| Baxter Healthcare | $1,012.50 | 2022 | |
| Medtronic, INC. | $134.20 | 2022 | |
| Astellas Pharma US INC | $113.40 | 2024 | Veozah |
| Mayne Pharma Commercial LLC | $95.88 | 2024-2025 | |
| Abbvie INC. | $70.36 | 2019-2025 | Liletta |
| Bayer Healthcare Pharmaceuticals INC. | $51.70 | 2019-2025 | |
| Pfizer INC. | $40.56 | 2021-2023 | |
| Millicent US INC | $38.13 | 2020-2025 | Femlyv |
| Exact Sciences Corporation | $34.39 | 2024-2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Dill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.